medigraphic.com
Instituto Nacional de Salud Pública

2018, Number 3

<< Back Next >>

salud publica mex 2018; 60 (3)

Hypertension in Mexican adults: prevalence, diagnosis and type of treatment. Ensanut MC 2016

Campos-Nonato I, Hernández-Barrera L, Pedroza-Tobías A, Medina C, Barquera S

Language: Spanish
References: 49
Page: 233-243
PDF size: 303.40 Kb.


ABSTRACT

Objective. To describe the prevalence, awareness and proportion of adults with an adequate control of hypertension. Materials and methods. Blood pressure was measured at 8 352 adults who participated in the Ensanut MC 2016. The adults who reported having diagnosis of hypertension or had systolic blood pressure values (TAS) ≥140mmHg or diastolic blood pressure (TAD) ≥90mmHg were classified as hypertensive. Hypertension was considered controlled when blood pressure was TAS ‹140mmHg and TAD ‹90mmHg. Results. The prevalence of hypertension was 25.5%. Of these, 40.0% were unaware of having high blood pressure. Of the hypertensive adults who had previous diagnosis of hypertension and receiving drug treatment (79.3%), 45.6% had blood pressure under control. Conclusions. A high percentage of adults are unaware of having hypertension and nearly half have inadequate control. The relevance of current programmes for diagnosing hypertension should be assessed, as well as the effectiveness of their control strategies.


REFERENCES

  1. World Health Organization. A global brief on hypertension. Silent killer, global public health crisis. Ginebra: WHO, 2013.

  2. Stamler J. Blood pressure and high blood pressure. Aspects of risk. Hypertension. 1991;18(supl 3):I95-207. https://doi.org/10.1161/01. HYP.18.3_Suppl.I95

  3. World Health Organization. Global status report on noncommunicable diseases 2010. Ginebra: WHO, 2011.

  4. Campos-Nonato I, Hernandez-Barrera L, Rojas-Martinez R, Pedroza A, Medina-Garcia C, Barquera-Cervera S. Hypertension: prevalence, early diagnosis, control and trends in Mexican adults. Salud Publica Mex. 2013;55(supl 2):S144-50. https://doi.org/10.21149/spm.v55s2.5110

  5. Secretaría de Salud, Dirección General de Epidemiología. Anuario de Morbilidad 1984-2016. Incidencia. Casos nuevos de enfermedad por grupo de edad. México: Secretaría de Salud, 2018 [citado abril 23, 2017]. Disponible en: http://www.epidemiologia.salud.gob.mx/anuario/2016/incidencia/ incidencia_casos_nuevos_enfermedad_grupo_edad.pdf

  6. Registros administrativos [internet]. Mortalidad. Conjunto de datos: Mortalidad general (1990-2016). Tabulación para mortalidad de la CIE [citado abril 23, 2017]. Aguascalientes: Instituto Nacional de Estadística y Geografía, 2017. Disponible en: http://www.inegi.org.mx/ sistemas/olap/Proyectos/bd/continuas/mortalidad/MortalidadGeneral. asp?s=est&c=11144&proy=mortgral_mg

  7. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1659-724. https://doi.org/10.1016/S0140- 6736(16)31679-8

  8. Global Burden of Disease 2016-Compare [internet]. Seattle, WA: Institute for Health Metrics and Evaluation. 2016 [citado abril 23, 2017]. Disponible en: http://vizhub.healthdata.org/gbd-compare

  9. Secretaría de Salud. Programa de Acción: Enfermedades Cardiovasculares e Hipertensión Arterial. México: SSa, 2001.

  10. Secretaría de Salud. Programa de Acción: Enfermedades Cardiovasculares e Hipertensión Arterial. México: Ssa-IMSS-ISSSTE, 2001 [citado abril 23, 2017]. Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/ enf_cardiovasculares.pdf

  11. Centro Nacional de Excelencia Tecnológica en Salud. Guía de práctica clínica para el diagnóstico y tratamiento de la hipertensión arterial en el primer nivel de atención. Ciudad de México: SSa, 2008.

  12. Romero-Martínez M, Shamah-Levy T, Cuevas-Nasu L, Méndez Gómez- Humarán I, Gaona-Pineda EB, Gómez-Acosta LM, Rivera-Dommarco JÁ, Hernández-Ávila M. Diseño metodológico de la Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Salud Publica Mex. 2017;59:299- 305. https://doi.org/10.21149/8593

  13. Meaney E, Alva F, Moguel R, Meaney A, Alva J, Webel R. Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart. 2000;84(1):64. https://doi.org/10.1136/heart.84.1.64

  14. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142-61. https://doi. org/10.1161/01.HYP.0000150859.47929.8e

  15. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. https://doi.org/10.1001/jama.2013.284427

  16. Lohman T, Roche A, Martorell R. Anthropometric standarization reference manual. Champlaign, IL: Human Kinetics, 1988.

  17. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Ginebra: WHO, 1995.

  18. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. https://doi.org/10.1161/CIRCULATIONAHA. 109.192644

  19. Greenland S. Basi methods for sensitivity analysis of biases. Int J Epidemiol. 1996;25(6):1107-16. https://doi.org/10.1093/ije/25.6.1107

  20. World Health Organization. World health statistics 2012. Ginebra: WHO, 2012.

  21. Mindell JS, Moody A, Vecino-Ortiz AI, Alfaro T, Frenz P, Scholes S, et al. Comparison of Health Examination Survey Methods in Brazil, Chile, Colombia, Mexico, England, Scotland, and the United States. Am J Epidemiol. 2017;186(6):648-58. https://doi.org/10.1093/aje/kwx045

  22. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380(9841):611-9. https://doi.org/10.1016/S0140-6736(12)60861-7

  23. Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27(5):963-75. https://doi. org/10.1097/HJH.0b013e3283282f65

  24. Sandberg K, Ji H. Sex differences in primary hypertension. Biol Sex Differ. 2012;3(1):7. https://doi.org/10.1186/2042-6410-3-7

  25. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med. 1989;149(4):780-8. https://doi.org/10.1001/archinte. 1989.00390040022005

  26. Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423. https://doi.org/10.1136/bmjopen- 2013-003423

  27. Paulose-Ram R, Gu Q, Kit B. Characteristics of U.S. adults with hypertension who are unaware of their hypertension, 2011-2014. Hyattsville, MD: National Center for Health Statistics, 2017.

  28. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11-9. https://doi.org/10.1097/00004872-200401000-00003

  29. Ghosh S, Mukhopadhyay S, Barik A. Sex differences in the risk profile of hypertension: a cross-sectional study. BMJ Open. 2016;6(7):e010085. https://doi.org/10.1136/bmjopen-2015-010085

  30. Chobanian AV. Improved hypertension control: cause for some celebration. JAMA. 2010;303(20):2082-3. https://doi.org/10.1001/ jama.2010.692

  31. Maimaris W, Paty J, Perel P, Legido-Quigley H, Balabanova D, Nieuwlaat R, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med. 2013;10(7):e1001490. https://doi.org/10.1371/journal.pmed.1001490

  32. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959-68. https://doi.org/10.1001/jama.2013.184182

  33. Gasse C, Hense HW, Stieber J, Doring A, Liese AD, Keil U. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens. 2001;15(1):27-36. https://doi. org/10.1038/sj.jhh.1001120

  34. Franklin SS, Wong ND. Hypertension and cardiovascular disease: contributions of the framingham heart study. Glob Heart. 2013;8(1):49-57. https://doi.org/10.1016/j.gheart.2012.12.004

  35. Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich). 2013;15(1):14-33. https://doi.org/10.1111/jch.12049

  36. Colhoun HM, Hemingway H, Poulter NR. Socio-economic status and blood pressure: an overview analysis. J Hum Hypertens. 1998;12(2):91- 110. https://doi.org/10.1038/sj.jhh.1000558

  37. Tedesco MA, Di Salvo G, Caputo S, Natale F, Ratti G, Iarussi D, et al. Educational level and hypertension: how socioeconomic differences condition health care. J Hum Hypertens. 2001;15(10):727-31. https://doi. org/10.1038/sj.jhh.1001249

  38. Mendis S, Johnston SC, Fan W, Oladapo O, Cameron A, Faramawi MF. Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. Bull World Health Organ. 2010;88(6):412-9. https://doi.org/10.2471/ BLT.08.062364

  39. Y iannakopoulou E, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12(3):243-9. https:// doi.org/10.1097/00149831-200506000-00010

  40. Fahey T, Schroeder K, Ebrahim S. Educational and organisational interventions used to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract. 2005;55(520):875-82.

  41. Bleich SN, Cutler DM, Adams AS, Lozano R, Murray CJ. Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ. 2007;335(7625):875. https://doi.org/10.1136/bmj.39350.617616.BE

  42. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162(9):1051-8. https://doi. org/10.1001/archinte.162.9.1051

  43. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):165-82. https://doi. org/10.1001/jama.2016.19043

  44. Gomez-Dantes H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, et al. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;388(10058):2386-402. https://doi. org/10.1016/S0140-6736(16)31773-1

  45. Jones DW, Hall JE. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension. 2004;43(1):1-3. https://doi.org/10.1161/01.HYP.0000110061.06674.ca

  46. Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345(18):1291-7. https://doi.org/10.1056/NEJMoa003417

  47. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288(15):1882-8. https://doi.org/10.1001/jama.288.15.1882

  48. DeVore AD, Sorrentino M, Arnsdorf MF, Ward RP, Bakris GL, Blankstein R. Predictors of hypertension control in a diverse general cardiology practice. J Clin Hypertens (Greenwich). 2010;12(8):570-7. https://doi. org/10.1111/j.1751-7176.2010.00298.x

  49. Ríos-Blancas MJ, Cahuana-Hurtado L, Lamadrid-Figueroa H, Lozano R. Cobertura efectiva del tratamiento de la hipertensión arterial en adultos en México por entidad federativa. Salud Publica Mex. 2017;59(2):154-164. https://doi.org/10.21149/8195




2020     |     www.medigraphic.com